CHRN revenueQ1 2027$41.48M
- Quarter YoY
- +148.1%
CHRN revenue was $41.48M in fiscal Q1 2027 (ended Aug 31, 2026), up 148.1% from a year earlier. For the full fiscal 2026 it was $71.60M. Fiscal 2026 is the highest of the 12 fiscal years on file.
For fiscal 2026 (ended May 31, 2026), ChronoScale Holdings Corporation reported $71.60M of revenue and -$50.32M of net income.
CHRN revenue was $41.48M in fiscal Q1 2027 (ended Aug 31, 2026), up 148.1% from a year earlier. For the full fiscal 2026 it was $71.60M. Fiscal 2026 is the highest of the 12 fiscal years on file.
CHRN net income was -$42.48M in fiscal Q1 2027 (ended Aug 31, 2026), compared with -$11.24M a year earlier. For the full fiscal 2026 it was -$50.32M.
CHRN diluted EPS was -$0.29 in fiscal Q1 2027 (ended Aug 31, 2026), compared with -$0.54 a year earlier. For the full fiscal 2026 it was -$0.36.
CHRN free cash flow was $11.56M in fiscal Q1 2027 (ended Aug 31, 2026), compared with -$882.0K a year earlier. For the full fiscal 2026 it was $12.19M. Fiscal 2026 is the highest of the 12 fiscal years on file.
| Line item | May 31, 2026 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $71.60M | $18.28M | $12.91M | $11.25M | $8.88M | $13.92M | $11.33M | $7.35M | $14.22M | $8.66M |
| Cost of revenue | $88.69M | $9.20M | $6.70M | $4.50M | $3.81M | $7.15M | $7.02M | $5.28M | $11.27M | $7.48M |
| Gross profit | -$17.09M | $9.08M | $6.21M | $6.75M | $5.07M | $6.76M | $4.31M | $2.07M | $2.95M | $1.18M |
| Research and development | - | $5.03M | $3.63M | $2.55M | $2.47M | $4.60M | $5.85M | $9.48M | $8.88M | $6.48M |
| Selling, general and admin | $19.81M | $10.69M | $10.99M | $10.72M | $7.70M | $7.41M | $11.66M | $10.71M | $10.85M | $7.00M |
| Operating income | -$37.50M | -$15.11M | -$15.56M | -$13.83M | -$13.29M | -$16.64M | -$27.03M | -$31.61M | -$27.59M | -$21.56M |
| Interest expense | - | $302.0K | $156.0K | $113.0K | $139.0K | $384.0K | $600.0K | $648.0K | $16.0K | $13.0K |
| Pre-tax income | -$49.30M | -$15.20M | -$15.08M | -$9.76M | -$15.82M | -$12.13M | -$26.99M | -$29.12M | -$23.47M | -$19.59M |
| Income tax | $0 | - | - | - | - | - | - | - | - | - |
| Net income | -$50.32M | -$15.20M | -$15.08M | -$9.76M | -$15.82M | -$12.13M | -$26.99M | -$29.12M | -$23.47M | -$19.59M |
| EPS, basic | -$0.36 | -$1.10 | -$1.16 | -$0.80 | -$2.21 | -$2.53 | -$6.60 | -$12.30 | -$28.05 | -$24.90 |
| EPS, diluted | -$0.36 | -$1.10 | -$1.16 | -$0.88 | -$2.21 | -$2.53 | -$6.60 | -$12.30 | -$30.75 | -$27.45 |
| Diluted shares | 138.7M | 13.9M | 13.0M | 12.3M | 7.2M | 4.8M | 4.1M | 2.4M | 1.2M | 973,933.333 |
| Line item | May 31, 2026 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $9.66M | $8.64M | $20.52M | $40.41M | $12.86M | $10.87M | $7.66M | $27.81M | $16.85M | $19.55M |
| Receivables | $12.54M | $5.64M | $4.63M | $4.66M | $3.22M | $5.21M | $3.66M | $2.76M | $1.78M | $2.07M |
| Inventory | - | $5.05M | $5.19M | $2.24M | $1.98M | $2.49M | $3.37M | $3.02M | $1.56M | $1.06M |
| Current assets | $44.25M | $20.21M | $31.04M | $47.80M | $18.42M | $18.81M | $14.97M | $34.94M | $20.68M | $25.20M |
| Goodwill | $54.51M | $431.0K | $431.0K | $0 | $0 | $189.0K | $189.0K | $189.0K | $189.0K | $189.0K |
| Total assets | $325.87M | $28.92M | $40.90M | $49.17M | $20.60M | $21.91M | $17.66M | $37.99M | $24.43M | $32.20M |
| Current liabilities | $86.89M | $8.12M | $9.20M | $6.86M | $4.97M | $7.83M | $10.08M | $9.16M | $6.33M | $8.62M |
| Short-term debt | $3.37M | - | - | $0 | $0 | $2.33M | $2.33M | $2.14M | - | - |
| Long-term debt | $474.0K | - | - | $1.99M | $1.99M | $407.0K | $2.65M | $4.83M | $156.0K | $246.0K |
| Total debt | $3.84M | - | - | $1.99M | $1.99M | $2.74M | $4.98M | $6.97M | $156.0K | $246.0K |
| Total liabilities | $143.84M | $16.31M | $15.46M | $11.95M | $16.16M | $15.12M | $14.93M | $16.60M | $17.89M | $23.39M |
| Shareholders' equity | $180.03M | $12.61M | $25.44M | $37.22M | $4.43M | $6.80M | $2.73M | $21.39M | $6.53M | $8.81M |
| Line item | May 31, 2026 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $39.07M | -$12.05M | -$14.69M | -$11.16M | -$8.76M | -$15.77M | -$22.16M | -$31.23M | -$25.00M | -$18.27M |
| Capital expenditures | $26.88M | $157.0K | $194.0K | $59.0K | $0 | $60.0K | $131.0K | $456.0K | $1.10M | $1.49M |
| Free cash flow | $12.19M | -$12.21M | -$14.88M | -$11.21M | -$8.76M | -$15.83M | -$22.30M | -$31.68M | -$26.09M | -$19.76M |
| Investing cash flow | -$25.17M | -$157.0K | -$5.17M | -$59.0K | $0 | -$60.0K | -$131.0K | -$456.0K | -$1.10M | -$1.49M |
| Financing cash flow | -$6.63M | $348.0K | $0 | $38.71M | $10.70M | $19.04M | $2.27M | $42.57M | $23.31M | $14.12M |
| Stock-based compensation | $1.30M | $1.86M | $2.55M | $2.33M | $2.41M | $2.25M | $2.87M | $2.41M | $3.12M | $1.73M |
| Depreciation and amortization | $60.34M | $1.70M | $887.0K | $1.02M | $620.0K | $690.0K | $1.01M | $1.20M | $1.85M | $933.0K |
| Line item | May 31, 2026 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | - | 41.6% | 14.8% | 26.6% | -36.2% | 22.8% | 54.1% | -48.3% | 64.2% | 62.6% |
| Gross margin | -23.9% | 49.7% | 48.1% | 60.0% | 57.1% | 48.6% | 38.0% | 28.1% | 20.7% | 13.6% |
| Operating margin | -52.4% | -82.7% | -120.5% | -123.0% | -149.6% | -119.6% | -238.5% | -429.9% | -194.0% | -248.9% |
| Net margin | -70.3% | -83.1% | -116.8% | -86.8% | -178.2% | -87.2% | -238.2% | -396.1% | -165.0% | -226.2% |
| Free cash flow margin | 17.0% | -66.8% | -115.3% | -99.7% | -98.6% | -113.8% | -196.8% | -430.9% | -183.5% | -228.2% |
| Return on equity | -28.0% | -120.6% | -59.3% | -26.2% | -356.9% | -178.5% | -989.4% | -136.1% | -359.4% | -222.4% |
| Return on assets | -15.4% | -52.6% | -36.9% | -19.9% | -76.8% | -55.4% | -152.9% | -76.7% | -96.1% | -60.8% |
| Current ratio | 0.51 | 2.49 | 3.37 | 6.97 | 3.70 | 2.40 | 1.48 | 3.81 | 3.27 | 2.92 |
| Debt to equity | 0.02 | - | - | 0.05 | 0.45 | 0.40 | 1.83 | 0.33 | 0.02 | 0.03 |
| Line item | Aug 31, 2026 | Mar 31, 2026 | Aug 31, 2025 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $41.48M | $2.14M | $16.72M | $4.13M | $4.95M | $3.76M | $4.85M | $4.61M | $4.70M | $4.12M | $3.55M | $3.33M |
| Cost of revenue | $45.63M | $1.07M | $23.88M | $1.92M | $2.31M | $1.80M | $2.48M | $2.15M | $2.45M | $2.12M | $1.87M | $1.64M |
| Gross profit | -$4.15M | $1.07M | $2.55M | $2.21M | $2.64M | $1.95M | $2.37M | $2.46M | $2.25M | $2.00M | $1.68M | $1.69M |
| Research and development | - | $583.0K | $550.0K | $777.0K | $1.12M | $1.14M | $1.31M | $1.16M | $1.40M | $1.15M | $946.0K | $887.0K |
| Selling, general and admin | $20.74M | $4.06M | $383.0K | $2.31M | $2.01M | $2.25M | $2.52M | $2.18M | $2.79M | $3.21M | $3.22M | $2.71M |
| Operating income | -$24.89M | -$5.62M | -$8.03M | -$2.64M | -$2.33M | -$3.26M | -$3.45M | -$2.93M | -$4.28M | -$4.45M | -$4.44M | -$3.65M |
| Interest expense | - | $143.0K | $18.0K | $79.0K | $74.0K | $57.0K | $66.0K | $64.0K | $61.0K | $112.0K | $66.0K | $34.0K |
| Net income | -$42.48M | -$6.88M | -$11.24M | -$2.07M | -$2.42M | -$3.43M | -$3.21M | -$3.37M | -$4.23M | -$4.39M | -$3.18M | -$4.30M |
| EPS, basic | -$0.29 | -$2.04 | -$0.54 | -$1.53 | -$1.99 | -$0.20 | -$0.22 | -$0.24 | -$0.31 | -$0.33 | -$0.24 | -$0.33 |
| EPS, diluted | -$0.29 | -$2.04 | -$0.54 | -$1.53 | -$1.99 | -$0.20 | -$0.22 | -$0.24 | -$0.31 | -$0.33 | -$0.24 | -$0.33 |
| Diluted shares | 145.4M | - | 138.2M | 20.3M | 18.2M | 17.4M | - | 14.1M | 13.6M | 13.3M | - | 13.1M |
| Line item | Aug 31, 2026 | Mar 31, 2026 | Aug 31, 2025 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $15.22M | $3.99M | $7.0K | $8.29M | $5.88M | $8.80M | $8.64M | $9.94M | $13.31M | $16.28M | $20.52M | $29.18M |
| Receivables | $7.56M | $4.54M | - | $6.96M | $6.52M | $7.24M | $5.64M | $5.87M | $5.05M | $4.83M | $4.63M | $3.40M |
| Inventory | - | $4.65M | - | $5.03M | $4.97M | $5.11M | $5.05M | $5.49M | $5.60M | $5.66M | $5.19M | $3.51M |
| Current assets | $30.69M | $14.05M | - | $21.07M | $18.64M | $20.52M | $20.21M | $22.36M | $24.72M | $27.60M | $31.04M | $36.75M |
| Goodwill | $54.39M | $431.0K | - | $431.0K | $431.0K | $431.0K | $431.0K | $431.0K | $431.0K | $431.0K | $431.0K | - |
| Total assets | $295.40M | $19.67M | - | $29.21M | $26.98M | $28.96M | $28.92M | $31.18M | $33.99M | $37.10M | $40.90M | $39.31M |
| Current liabilities | $101.17M | $9.09M | - | $7.51M | $7.70M | $7.31M | $8.12M | $7.83M | $10.13M | $9.54M | $9.20M | $7.86M |
| Short-term debt | $10.54M | - | - | - | - | - | - | - | - | - | - | $2.00M |
| Long-term debt | $151.0K | - | - | - | - | - | - | - | - | - | - | $0 |
| Total debt | $10.69M | - | - | - | - | - | - | - | - | - | - | $2.00M |
| Total liabilities | $144.75M | $13.93M | - | $14.34M | $14.93M | $14.91M | $16.31M | $15.93M | $16.18M | $15.82M | $15.46M | $10.70M |
| Shareholders' equity | $150.65M | $2.09M | $89.23M | $14.87M | $12.06M | $14.05M | $12.61M | $15.26M | $17.81M | $21.28M | $25.44M | $28.61M |
| Line item | Aug 31, 2026 | Mar 31, 2026 | Aug 31, 2025 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $14.63M | -$2.12M | $95.0K | -$2.28M | -$2.67M | -$3.47M | -$1.58M | -$3.35M | -$2.90M | -$4.21M | -$3.64M | -$2.59M |
| Capital expenditures | $3.06M | $0 | $977.0K | $8.0K | $0 | $8.0K | $43.0K | $17.0K | $55.0K | $42.0K | $53.0K | $141.0K |
| Free cash flow | $11.56M | -$2.12M | -$882.0K | -$2.29M | -$2.67M | -$3.47M | -$1.63M | -$3.37M | -$2.96M | -$4.26M | -$3.70M | -$2.73M |
| Investing cash flow | -$3.06M | $0 | -$977.0K | -$8.0K | $0 | -$8.0K | -$43.0K | -$17.0K | -$55.0K | -$42.0K | -$5.03M | -$141.0K |
| Financing cash flow | -$6.00M | $4.95M | -$1.51M | $4.69M | -$265.0K | $3.66M | $348.0K | $0 | $0 | $0 | $0 | $0 |
| Stock-based compensation | $10.13M | $114.0K | $90.0K | $406.0K | $284.0K | $376.0K | $479.0K | $441.0K | $514.0K | $424.0K | $928.0K | $537.0K |
| Depreciation and amortization | $15.34M | $454.0K | $14.49M | $407.0K | $397.0K | $406.0K | $432.0K | $424.0K | $428.0K | $414.0K | $258.0K | $167.0K |
| Line item | Aug 31, 2026 | Mar 31, 2026 | Aug 31, 2025 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 148.1% | - | - | -10.4% | 5.3% | -8.9% | 36.5% | 38.4% | 41.3% | 60.6% | -12.9% | 9.2% |
| Gross margin | -10.0% | 50.2% | 15.2% | 53.5% | 53.3% | 51.9% | 48.9% | 53.3% | 47.9% | 48.5% | 47.3% | 50.6% |
| Operating margin | -60.0% | -262.4% | -48.1% | -63.9% | -47.2% | -86.7% | -71.2% | -63.6% | -91.1% | -107.9% | -124.9% | -109.8% |
| Net margin | -102.4% | -321.6% | -67.3% | -50.2% | -48.8% | -91.3% | -66.3% | -73.0% | -89.9% | -106.5% | -89.5% | -129.3% |
| Free cash flow margin | 27.9% | -99.2% | -5.3% | -55.3% | -53.9% | -92.5% | -33.6% | -73.1% | -62.9% | -103.3% | -104.1% | -82.0% |
| Current ratio | 0.30 | 1.55 | - | 2.81 | 2.42 | 2.81 | 2.49 | 2.85 | 2.44 | 2.89 | 3.37 | 4.68 |
| Debt to equity | 0.07 | - | - | - | - | - | - | - | - | - | - | 0.07 |
Source: XBRL data ChronoScale Holdings Corporation files with the SEC, latest filing dated Oct 14, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures and share counts are restated for stock splits the filings show: 1-for-7, first reported May 10, 2016; 1-for-15, first reported Apr 30, 2020.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| CHRN | $71.60M | +291.7% | -$50.32M | -70.3% | $1.45B |
| ASML | €32.67B | +15.6% | €9.61B | 29.4% | $576.26B |
| LRCX | $26.13B | +33.4% | $8.45B | 32.3% | $282.21B |
| TMO | $47.35B | +8.3% | $7.07B | 14.9% | $259.44B |
| DE | $47.98B | +8.0% | $4.87B | 10.2% | $181.60B |
| DHR | $25.61B | +5.5% | $4.33B | 16.9% | $163.93B |
| ETN | $31.98B | +20.1% | $3.90B | 12.2% | $137.13B |
| JCI | $25.67B | +8.8% | $2.85B | 11.1% | $83.63B |
| ITW | $16.65B | +4.8% | $3.23B | 19.4% | $81.71B |